(19)
(11) EP 2 550 258 A2

(12)

(88) Date of publication A3:
22.12.2011

(43) Date of publication:
30.01.2013 Bulletin 2013/05

(21) Application number: 11709579.4

(22) Date of filing: 10.03.2011
(51) International Patent Classification (IPC): 
C07D 295/112(2006.01)
C07D 417/04(2006.01)
C07C 311/51(2006.01)
A61K 31/495(2006.01)
A61P 35/00(2006.01)
C07D 295/195(2006.01)
C07D 211/58(2006.01)
A61K 31/451(2006.01)
A61K 31/18(2006.01)
(86) International application number:
PCT/US2011/027895
(87) International publication number:
WO 2011/119345 (29.09.2011 Gazette 2011/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 25.03.2010 US 317575 P

(71) Applicant: Abbvie Inc.
North Chicago, IL 60064 (US)

(72) Inventors:
  • DING, Hong
    Lincolnshire, Illinois 60069 (US)
  • ELMORE, Steven
    Northbrook, Illinois 60062 (US)
  • HEXAMER, Laura
    Grayslake, Illinois 60030 (US)
  • KUNZER, Aaron, R.
    Arlington, Illinois 60004 (US)
  • PARK, Cheol-Min
    Singapore 637371 (SG)
  • SOUERS, Andrew, J.
    Evanston, Illinois 60202 (US)
  • SULLIVAN, Gerard
    Lake Villa, Illinois 60046 (US)
  • WENDT, Michael
    Vernon Hills, Illinois 60061 (US)

(74) Representative: Modiano, Micaela Nadia et al
Modiano & Partners (DE) Thierschstrasse 11
80538 München
80538 München (DE)

   


(54) APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES